
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| DHC | +17.88% | +58.26% | +9.61% | +61% | 
| S&P | +17.35% | +108.64% | +15.84% | +418% | 
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that offers short term and long term residential care, and other services for residents where it pay fees to the operator to manage the communities for its account. The company was founded on December 16, 1998 and is headquartered in Newton, MA.
Occupancy and revenue were down notably from pre-pandemic levels, and a big financing problem isn't being solved.
Investors applauded the healthcare REIT's fourth-quarter update.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $382.71M | 3.0% | 
| Gross Profit | $3.87M | 475.3% | 
| Gross Margin | 1.01% | 1.3% | 
| Market Cap | $863.68M | 17.7% | 
| Net Income | -$91.64M | 6.4% | 
| EBITDA | $58.88M | -0.6% | 
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $148.58M | -45.0% | 
| Inventory | 0 | 0.0% | 
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.66B | -9.7% | 
| Short Term Debt | $0.00M | 0.0% | 
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -5.68% | 0.8% | 
| Return On Invested Capital | -2.77% | -1.3% | 
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $18.84M | 471.7% | 
| Operating Free Cash Flow | $53.02M | 19.7% | 
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change | 
|---|---|---|---|---|---|
| Price to Book | 0.49 | 0.27 | 0.30 | 0.44 | 35.97% | 
| Price to Sales | 0.68 | 0.37 | 0.38 | 0.56 | 12.93% | 
| Price to Tangible Book Value | 0.50 | 0.27 | 0.30 | 0.45 | 35.77% | 
| Enterprise Value to EBITDA | 74.67 | 50.96 | 48.64 | 57.17 | -0.44% | 
| Return on Equity | -17.2% | -17.2% | -14.0% | -14.3% | -5.34% | 
| Total Debt | $2.97B | $2.93B | $2.82B | $2.66B | -9.75% | 
DHC earnings call for the period ending September 30, 2021.
DHC earnings call for the period ending June 30, 2021.
DHC earnings call for the period ending March 31, 2021.
DHC earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.